We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
+$7.71M
Cap. Flow
+$92.4M
Cap. Flow %
7.09%
Top 10 Hldgs %
6.04%
Holding
1,409
New
392
Increased
321
Reduced
279
Closed
417

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$9.84M
2
LH icon
Labcorp
LH
+$8.89M
3
HUBB icon
Hubbell
HUBB
+$7.76M
4
SNY icon
Sanofi
SNY
+$7.7M
5
JHG
Janus Henderson
JHG
+$7.68M

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$10.4M
2
FAST icon
Fastenal
FAST
+$10.2M
3
HCA icon
HCA Healthcare
HCA
+$9.44M
4
SCHW
Charles Schwab
SCHW
+$9.09M
5
NVS icon
Novartis
NVS
+$9.01M

Sector Composition

Rank Sector Weight
1 Financials 17%
2 Healthcare 16.16%
3 Consumer Discretionary 11.61%
4 Industrials 11.13%
5 Technology 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLPI icon
151
Gaming and Leisure Properties
GLPI
$12.4B
$2.36M 0.18%
46,450
-2,972
-6% -$146K
THS
152
DELISTED
Treehouse Foods
THS
$2.34M 0.18%
+86,298
New +$2.74M
PNR icon
153
Pentair
PNR
$10.7B
$2.33M 0.18%
+26,687
New +$2.54M
UTHR icon
154
United Therapeutics
UTHR
$22.1B
$2.31M 0.18%
+7,502
New +$2.57M
CPRX
155
DELISTED
Catalyst Pharmaceutical
CPRX
$2.31M 0.18%
+95,079
New +$2.14M
FTS icon
156
Fortis
FTS
$28.6B
$2.3M 0.18%
+50,472
New +$2.2M
REYN icon
157
Reynolds Consumer Products
REYN
$5.51B
$2.3M 0.18%
96,257
-8,748
-8% -$221K
MRVL icon
158
Marvell Technology
MRVL
$191B
$2.27M 0.17%
+36,931
New +$3.58M
FLO icon
159
Flowers Foods
FLO
$1.52B
$2.27M 0.17%
+119,156
New +$2.28M
NVT icon
160
nVent Electric
NVT
$27.1B
$2.26M 0.17%
+43,200
New +$2.73M
AYI icon
161
Acuity Brands
AYI
$10.7B
$2.26M 0.17%
8,598
-473
-5% -$143K
VCYT icon
162
Veracyte
VCYT
$3.73B
$2.26M 0.17%
+76,342
New +$2.91M
SMG icon
163
ScottsMiracle-Gro
SMG
$3.61B
$2.25M 0.17%
+40,920
New +$2.65M
REG icon
164
Regency Centers
REG
$13.9B
$2.24M 0.17%
30,404
+12,725
+72% +$926K
ADP icon
165
Automatic Data Processing
ADP
$108B
$2.24M 0.17%
+7,340
New +$2.21M
SBS icon
166
Sabesp
SBS
$17.7B
$2.24M 0.17%
+645,989
New +$2.06M
OMCL icon
167
Omnicell
OMCL
$1.68B
$2.23M 0.17%
+63,921
New +$2.53M
GIS icon
168
General Mills
GIS
$20.2B
$2.23M 0.17%
+37,333
New +$2.24M
THC icon
169
Tenet Healthcare
THC
$20.9B
$2.23M 0.17%
16,590
+9,113
+122% +$1.2M
WTFC icon
170
Wintrust Financial
WTFC
$10.9B
$2.22M 0.17%
+19,782
New +$2.44M
ZBH icon
171
Zimmer Biomet
ZBH
$18.5B
$2.22M 0.17%
19,634
+16,874
+611% +$1.81M
NVR icon
172
NVR
NVR
$17.1B
$2.21M 0.17%
305
-86
-22% -$654K
AON icon
173
Aon
AON
$75.6B
$2.2M 0.17%
5,514
-11,829
-68% -$4.54M
FR icon
174
First Industrial Realty Trust
FR
$8.35B
$2.19M 0.17%
40,674
+8,205
+25% +$444K
SHEL icon
175
Shell
SHEL
$250B
$2.17M 0.17%
29,655
-34,245
-54% -$2.31M
5 6
7
8 9

Similar funds

BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return

Campbell & Co Investment Adviser's Q1 2025 Portfolio in Review

As of Q1 2025, Campbell & Co Investment Adviser held 1,409 positions worth $1.3B, up 0.6% from $1.3B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Campbell & Co Investment Adviser deployed $92.4M of net new capital in Q1 2025, opening 392 new positions and adding to 321 existing holdings. Its largest new stake was Synchrony: 159,080 shares worth $8.42M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $9.01M trimmed.

  • Campbell & Co Investment Adviser's largest Q1 2025 buy was Synchrony: 159,080 shares worth $8.42M.
  • Campbell & Co Investment Adviser added most to Labcorp in Q1 2025, an estimated $8.89M increase.
  • Campbell & Co Investment Adviser's biggest Q1 2025 reduction was Novartis, cutting an estimated $9.01M.
  • Campbell & Co Investment Adviser fully exited Intercontinental Exchange in Q1 2025, selling an estimated $10.4M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6% of its $1.3B portfolio in Q1 2025.
  • Campbell & Co Investment Adviser opened 392 new positions and closed 417 in Q1 2025.
  • Campbell & Co Investment Adviser's portfolio value rose 0.6% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.